These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21060814)
1. FSHD: a repeat contraction disease finally ready to expand (our understanding of its pathogenesis). Pearson CE PLoS Genet; 2010 Oct; 6(10):e1001180. PubMed ID: 21060814 [No Abstract] [Full Text] [Related]
2. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811 [TBL] [Abstract][Full Text] [Related]
3. In junk we trust: repetitive DNA, epigenetics and facioscapulohumeral muscular dystrophy. Neguembor MV; Gabellini D Epigenomics; 2010 Apr; 2(2):271-87. PubMed ID: 22121874 [TBL] [Abstract][Full Text] [Related]
4. Nanopore direct RNA sequencing detects DUX4-activated repeats and isoforms in human muscle cells. Mitsuhashi S; Nakagawa S; Sasaki-Honda M; Sakurai H; Frith MC; Mitsuhashi H Hum Mol Genet; 2021 May; 30(7):552-563. PubMed ID: 33693705 [TBL] [Abstract][Full Text] [Related]
5. A unifying genetic model for facioscapulohumeral muscular dystrophy. Lemmers RJ; van der Vliet PJ; Klooster R; Sacconi S; Camaño P; Dauwerse JG; Snider L; Straasheijm KR; van Ommen GJ; Padberg GW; Miller DG; Tapscott SJ; Tawil R; Frants RR; van der Maarel SM Science; 2010 Sep; 329(5999):1650-3. PubMed ID: 20724583 [TBL] [Abstract][Full Text] [Related]
6. Genetics. Exposing a DUX tale. Mahadevan MS Science; 2010 Sep; 329(5999):1607-8. PubMed ID: 20929834 [No Abstract] [Full Text] [Related]
7. Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy. Greco A; Goossens R; van Engelen B; van der Maarel SM Clin Genet; 2020 Jun; 97(6):799-814. PubMed ID: 32086799 [TBL] [Abstract][Full Text] [Related]
8. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. Lemmers RJ; Wohlgemuth M; Frants RR; Padberg GW; Morava E; van der Maarel SM Am J Hum Genet; 2004 Dec; 75(6):1124-30. PubMed ID: 15467981 [TBL] [Abstract][Full Text] [Related]
9. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4. Sasaki-Honda M; Jonouchi T; Arai M; Hotta A; Mitsuhashi S; Nishino I; Matsuda R; Sakurai H Hum Mol Genet; 2018 Dec; 27(23):4024-4035. PubMed ID: 30107443 [TBL] [Abstract][Full Text] [Related]
10. The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy. Himeda CL; Jones PL Annu Rev Genomics Hum Genet; 2019 Aug; 20():265-291. PubMed ID: 31018108 [TBL] [Abstract][Full Text] [Related]
11. SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy. Robin JD; Ludlow AT; Batten K; Gaillard MC; Stadler G; Magdinier F; Wright WE; Shay JW Genome Res; 2015 Dec; 25(12):1781-90. PubMed ID: 26359233 [TBL] [Abstract][Full Text] [Related]
12. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338 [TBL] [Abstract][Full Text] [Related]
14. The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. van der Maarel SM; Frants RR Am J Hum Genet; 2005 Mar; 76(3):375-86. PubMed ID: 15674778 [No Abstract] [Full Text] [Related]
15. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683 [TBL] [Abstract][Full Text] [Related]
16. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. van Overveld PG; Lemmers RJ; Sandkuijl LA; Enthoven L; Winokur ST; Bakels F; Padberg GW; van Ommen GJ; Frants RR; van der Maarel SM Nat Genet; 2003 Dec; 35(4):315-7. PubMed ID: 14634647 [TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD). Wood-Allum C; Brennan P; Hewitt M; Lowe J; Tyfield L; Wills A Neuropathol Appl Neurobiol; 2004 Apr; 30(2):188-91. PubMed ID: 15043716 [No Abstract] [Full Text] [Related]
18. Intronic Goossens R; van den Boogaard ML; Lemmers RJLF; Balog J; van der Vliet PJ; Willemsen IM; Schouten J; Maggio I; van der Stoep N; Hoeben RC; Tapscott SJ; Geijsen N; Gonçalves MAFV; Sacconi S; Tawil R; van der Maarel SM J Med Genet; 2019 Dec; 56(12):828-837. PubMed ID: 31676591 [TBL] [Abstract][Full Text] [Related]
19. PAX7 target gene repression associates with FSHD progression and pathology over 1 year. Banerji CRS Hum Mol Genet; 2020 Aug; 29(13):2124-2133. PubMed ID: 32347924 [TBL] [Abstract][Full Text] [Related]